Table 1 Baseline demographic and clinical characteristics of children enrolled in the study
Variable | n = 101 |
|---|---|
Age (median, IQR) | 3 (1 months, 9 years) |
<1 year | 25 (25) |
1–5 years | 33 (33) |
6–10 years | 26 (26) |
11–17 years | 17 (17) |
Male (n %) | 52 (52) |
PIM-2 score (median, IQR) | 12 (8–26) |
PELOD score at admission (median, IQR) | 21 (20–22) |
Weight (Kg), median (IQR) | 12 (5–19) |
Duration of sun exposure in hours/day (only exposed parts) (median, IQR) | 2 (0.5–3.5) |
Admission season (n %) | |
Nov–Dec | 38 (38) |
Rest of the year | 63 (63) |
Nutritional status (n %) | |
Normal | 32 (31.7) |
Moderately undernourished (−2 to −3 SD) | 39 (38.6) |
Severely undernourished (<−3 SD) | 30 (29.7) |
Admitting diagnosis, n (%) | |
Severe sepsis/septic shock | 19 (19) |
Pneumonia | 19 (19) |
Meningitis | 16 (16) |
Seizure disorder | 12 (12) |
Cardiac illness | 10 (10) |
Tuberculosis | 3 (3) |
Malaria | 3 (3) |
Hepatic failure | 2 (2) |
Raised ICP | 1 (1) |
Any other | 16 (16) |
Underlying illness (n %) | |
Congenital heart disease | 9 (9) |
Nephrotic syndrome | 3 (3) |
Genetic/neurometabolic disorders | 3 (3) |
Tubercular meningitis | 1 (1) |
Others including autoimmune/immunodeficiency disorders | 4 (4) |
Neurological illness | 15 (15) |
Symptomatic hypocalcemia at admission (n %) | 15 (15) |
Laboratory investigations [mean (SD) or median (IQR)] | |
Total calcium (mg/dL) | 8 (1) |
Phosphate (mg/dL) | 3.3 (0.5) |
Ionized calcium (mmol/L) | 0.65 (0.25) |
Alkaline phosphatase (IU/L) | 159 (123–343) |
SGOT (U/L) | 57 (34–191) |
SGPT (U/L) | 39 (22–114) |
Albumin (g/dL) | 2.9 (0.4) |
Creatinine (mg/dL) | 0.6 (0.4–0.7) |
Hemoglobin (g/dL) | 9.7 (2) |